StockNews.com upgraded shares of Boston Scientific (NYSE:BSX – Free Report) from a hold rating to a buy rating in a report issued on Thursday morning. Other equities research analysts have also issued reports about the stock. Barclays lifted their price target on shares of Boston Scientific from $70.00 to $78.00 and gave the company an […]
Boston Scientific (NYSE:BSX – Free Report) had its price objective boosted by Citigroup from $85.00 to $87.00 in a research note issued to investors on Wednesday, Benzinga reports. Citigroup currently has a buy rating on the medical equipment provider’s stock. Several other research firms have also recently weighed in on BSX. StockNews.com cut Boston Scientific […]
US Bancorp DE lessened its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 15.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 376,673 shares of the medical equipment provider’s stock after selling 67,064 shares during the period. US Bancorp DE’s holdings in Boston Scientific […]
FineMark National Bank & Trust lessened its holdings in Aflac Incorporated (NYSE:AFL – Free Report) by 12.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,231 shares of the financial services provider’s stock after selling 452 shares during the period. […]
Congress Wealth Management LLC DE reduced its holdings in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 17.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 105,917 shares of the medical equipment provider’s stock after selling 22,076 shares during the quarter. Congress […]